• Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=32144432; PubMed=34275013).
  

PubMed=32144432; DOI=10.1007/s00280-020-04045-9
Hiroaki Goto, Yuki Yoshino, Mieko Ito, Jun-ichi Nagai, Tadashi Kumamoto, Takesi Inukai, Yukari Sakurai, Naoyuki Miyagawa, Dai Keino, Tomoko Yokosuka, Fuminori Iwasaki ...Show all 14 authors... , Satoshi Hamanoue, Masae Shiomi, Shoko Goto; Show fewer authors
Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.
Cancer Chemother. Pharmacol. 85:773-783(2020)

PubMed=34275013; DOI=10.1007/s00280-021-04321-2
Hiroaki Goto, Yuki Yoshino, Mieko Ito, Jun-ichi Nagai, Tadashi Kumamoto, Takesi Inukai, Yukari Sakurai, Naoyuki Miyagawa, Dai Keino, Tomoko Yokosuka, Fuminori Iwasaki ...Show all 14 authors... , Satoshi Hamanoue, Masae Shiomi, Shoko Goto; Show fewer authors
Correction to: Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.
Cancer Chemother. Pharmacol. 88:1055-1056(2021)

PubMed=35124168; DOI=10.1016/j.jsbmb.2022.106068
Minori Tamai, Shin Kasai, Koshi Akahane, Thao Nguyen Thu, Keiko Kagami, Chiaki Komatsu, Masako Abe, Atsushi Watanabe, Kumiko Goi, Kunio Miyake, Toshiya Inaba ...Show all 17 authors... , Junko Takita, Hiroaki Goto, Masayoshi Minegishi, Shotaro Iwamoto, Kanji Sugita, Takeshi Inukai; Show fewer authors
Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
J. Steroid Biochem. Mol. Biol. 218:106068.1-106068.12(2022)